Patients affected by demyelinating diseases pay a high price in terms of quality of life, which N2B-patch aims to decrease while contributing to increased independence, more social inclusion, as well as improved quality of life for the patients and their surroundings.
With its described advantages regarding improved personalised medicine, potential cost reduction and novel application, N2B-patch has a huge potential of contributing to the sustainability and efficiency of European health care systems as well as to a positive and meaningful change for the benefit of society.
Share N2B-patch |
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 721098
Copyright N2B-patch (Fraunhofer IGB) 2024 >©
Designed with by pixagentur